3.15 26% Core EBITDA/t (US$/t)) 111 122 90 23% 110 89 24% Net Operating Debt to Equity 0.54 0.57 0.88 (39)% 0.54 0.88 (39)% Note: (1) Consolidated financials are based upon elimination of intra-company

upgraded CPN’s rating and its ratings of senior unsecured debentures to “AA” from “AA-“. The upgrades reflect CPN’s stronger financial profile, driven by solid operating performance and reliable streams of

Ref. DBP. 111 / 2020 August 10, 2020 Subject : Clarification on Operating Results for the 2nd quarter and 6-month period ending June 30, 2020 To : President The Stock Exchange of Thailand Diamond

Part 4: Financial position and operating results 13. Significant financial information 14. Financial position and operating results of REIT 15. Trustee’s opinions on REIT’s performance Part 5

the loan tenor from September 30, 2017 to November 15, 2017 to assist GSTEL who was still in the process of seeking funds from external source for their working capital as detail described below; Total

operating income ratio 24.3% 21.2% 27.3% 3.1% (3.0)% 22.7% 24.5% (1.8)% Expense to operating income ratio 56.2% 43.5% 45.5% 12.7% 10.7% 45.4% 43.5% 1.9% Return on average assets * 1.04% 1.14% 1.10% (0.10

Flow from Operating 255.4 188.0 Cash Flow from Investment (932.9) (2.9) Cash Flow from Financing (0.4) 0.0 Net Cash Flow 820.0 1,250 (Unit : THB mn) The Company has net cash flow as at 31st March, 2018

“SORKON” and its subsidiaries (“the company”) would like to clarify the operating results for Quarter 1/2018 as follows: Revenue and Net Sales The Company recorded its total revenue of Baht 696.5 million

Company Limited and its subsidiaries (“the Company”) would like to clarify herewith the operating result for the year 2018 as follows:- Financial Position As at 31 December 2018, total consolidated assets

. DOD2019/004 February 20, 2019 Subject: Management’s discussion and analysis of the Company’s operating results for the year 2018 period To: President The Stock Exchange of Thailand DOD Biotech Public